Actual Medicinal Product (AMP) Evra transdermal patches (Dowelhurst Ltd)

Stability Information

Stability
not_set logo We do not have stability information for these medicines and therefore cannot make a recommendation on suitability in an MCA.
Notes
There are no stability notes available for this medicine.
Generic
Ethinylestradiol + Norelgestromin
Formulation
Ethinylestradiol 33.9micrograms/24hours / Norelgestromin 203micrograms/24hours transdermal patches
  • Ethinylestradiol + Norelgestromin
    • Ethinylestradiol 33.9micrograms/24hours / Norelgestromin 203micrograms/24hours transdermal patches

      • Evra transdermal patches (Dowelhurst Ltd)